Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Behzadi MA"'
Autor:
Behzadi Mahsa, Demidem Aicha, Morvan Daniel, Schwartz Laurent, Stepien Georges, Steyaert Jean-Marc
Publikováno v:
Journal of Integrative Bioinformatics, Vol 7, Iss 3, Pp 192-207 (2010)
We study, in this paper, a model for the core of the system of the Glycerophospholipid metabolism in the murine cells. It comprises the simple and enzymatic reactions of PhosphatidylEthanolamine and the PhosphatidylCholine . The model’s general str
Externí odkaz:
https://doaj.org/article/fc0970a496e4456ead9129b9306f704a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Allerton CMN; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Arcari JT; Pfizer Research & Development, Groton, Connecticut 06340, United States., Aschenbrenner LM; Pfizer Research & Development, Groton, Connecticut 06340, United States., Avery M; Pfizer Research & Development, Groton, Connecticut 06340, United States., Bechle BM; Pfizer Research & Development, Groton, Connecticut 06340, United States., Behzadi MA; Pfizer Research & Development, Pearl River, New York 10965, United States., Boras B; Pfizer Research & Development, La Jolla, California 92121, United States., Buzon LM; Pfizer Research & Development, Groton, Connecticut 06340, United States., Cardin RD; Pfizer Research & Development, Pearl River, New York 10965, United States., Catlin NR; Pfizer Research & Development, Groton, Connecticut 06340, United States., Carlo AA; Pfizer Research & Development, Groton, Connecticut 06340, United States., Coffman KJ; Pfizer Research & Development, Groton, Connecticut 06340, United States., Dantonio A; Pfizer Research & Development, Groton, Connecticut 06340, United States., Di L; Pfizer Research & Development, Groton, Connecticut 06340, United States., Eng H; Pfizer Research & Development, Groton, Connecticut 06340, United States., Farley KA; Pfizer Research & Development, Groton, Connecticut 06340, United States., Ferre RA; Pfizer Research & Development, La Jolla, California 92121, United States., Gernhardt SS; Pfizer Research & Development, Groton, Connecticut 06340, United States., Gibson SA; Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah 84322, United States., Greasley SE; Pfizer Research & Development, La Jolla, California 92121, United States., Greenfield SR; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Hurst BL; Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah 84322, United States., Kalgutkar AS; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Kimoto E; Pfizer Research & Development, Groton, Connecticut 06340, United States., Lanyon LF; Pfizer Research & Development, Groton, Connecticut 06340, United States., Lovett GH; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Lian Y; Pfizer Research & Development, Groton, Connecticut 06340, United States., Liu W; Pfizer Research & Development, La Jolla, California 92121, United States., Martínez Alsina LA; Pfizer Research & Development, Groton, Connecticut 06340, United States., Noell S; Pfizer Research & Development, Groton, Connecticut 06340, United States., Obach RS; Pfizer Research & Development, Groton, Connecticut 06340, United States., Owen DR; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Patel NC; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Rai DK; Pfizer Research & Development, Groton, Connecticut 06340, United States., Reese MR; Pfizer Research & Development, Groton, Connecticut 06340, United States., Rothan HA; Pfizer Research & Development, Pearl River, New York 10965, United States., Sakata S; Pfizer Research & Development, La Jolla, California 92121, United States., Sammons MF; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Sathish JG; Pfizer Research & Development, Pearl River, New York 10965, United States., Sharma R; Pfizer Research & Development, Groton, Connecticut 06340, United States., Steppan CM; Pfizer Research & Development, Groton, Connecticut 06340, United States., Tuttle JB; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Verhoest PR; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Wei L; Pfizer Research & Development, Groton, Connecticut 06340, United States., Yang Q; Pfizer Research & Development, Cambridge, Massachusetts 02139, United States., Yurgelonis I; Pfizer Research & Development, Pearl River, New York 10965, United States., Zhu Y; Pfizer Research & Development, Pearl River, New York 10965, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Aug 22; Vol. 67 (16), pp. 13550-13571. Date of Electronic Publication: 2024 Apr 30.
Autor:
Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Moderna, Cambridge, MA, USA., Feser J; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Naficy A; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Bernstein DI; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Guptill J; Duke Early Phase Clinical Research Unit, Duke Clinical Research Institute, Durham, NC, USA., Walter EB; Duke Early Phase Clinical Research Unit, Duke Clinical Research Institute, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA., Berlanda-Scorza F; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.; GSK, Siena, Italy., Stadlbauer D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Wilson PC; Section of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL, USA.; The Committee on Immunology, University of Chicago, Chicago, IL, USA., Aydillo T; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Behzadi MA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bhavsar D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Bliss C; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Capuano C; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Carreño JM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chromikova V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Claeys C; GSK, Wavre, Belgium.; Spmt-Arista Asbl, Brussels, Belgium., Coughlan L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Freyn AW; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gast C; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., Javier A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Jiang K; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mariottini C; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., McMahon M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., McNeal M; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Solórzano A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Pfizer, Pearl River, NY, USA., Strohmeier S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria., Sun W; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Van der Wielen M; GSK, Wavre, Belgium., Innis BL; Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. florian.krammer@mssm.edu.
Publikováno v:
Nature medicine [Nat Med] 2021 Jan; Vol. 27 (1), pp. 106-114. Date of Electronic Publication: 2020 Dec 07.
Autor:
Carreño JM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA., McDonald JU; Division of Virology, National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar EN6 3QG, UK., Hurst T; Division of Virology, National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar EN6 3QG, UK., Rigsby P; Division of Analytical and Biological Sciences, National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar EN6 3QG, UK., Atkinson E; Division of Analytical and Biological Sciences, National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar EN6 3QG, UK., Charles L; Division of Virology, National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar EN6 3QG, UK., Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA., Behzadi MA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA., Strohmeier S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA.; Department of Biotechnology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria., Coughlan L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA., Aydillo T; Department of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA., Brandenburg B; Janssen Vaccines & Prevention BV, 2333 CP Leiden, The Netherlands., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA., Kaszas K; Janssen Vaccines & Prevention BV, 2333 CP Leiden, The Netherlands., Levine MZ; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Manenti A; VisMederi Research srl, 53100 Siena, Italy., McDermott AB; Vaccine Immunology Program (VIP), Vaccine Research Center (VRC), National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Muchene L; Janssen Vaccines & Prevention BV, 2333 CP Leiden, The Netherlands., Narpala SR; Vaccine Immunology Program (VIP), Vaccine Research Center (VRC), National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Perera RAPM; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Salisch NC; Janssen Vaccines & Prevention BV, 2333 CP Leiden, The Netherlands., Valkenburg SA; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Zhou F; Influenza Center, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway.; K.G. Jebsen Center for influenza vaccines, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway., Engelhardt OG; Division of Virology, National Institute for Biological Standards and Control (NIBSC), South Mimms, Potters Bar EN6 3QG, UK., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2020 Nov 09; Vol. 8 (4). Date of Electronic Publication: 2020 Nov 09.
Autor:
Behzadi MA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Choi A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Duehr J; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Feyznezhad R; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Upadhyay C; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Schotsaert M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Global Health and Emerging Pathogens Institute, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. raffael.nachbagauer@mssm.edu.
Publikováno v:
Scientific reports [Sci Rep] 2020 Jun 16; Vol. 10 (1), pp. 9750. Date of Electronic Publication: 2020 Jun 16.
Autor:
Nachbagauer R; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Salaun B; 2GSK, Rixensart, Belgium., Stadlbauer D; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Behzadi MA; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Friel D; 3GSK, Wavre, Belgium., Rajabhathor A; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Choi A; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 4Graduate School of Biomedical Services, Icahn School of Medicine at Mount Sinai, New York, NY USA., Albrecht RA; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 5Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA., Debois M; 3GSK, Wavre, Belgium., García-Sastre A; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 5Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 6Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA., Rouxel RN; 2GSK, Rixensart, Belgium., Sun W; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Palese P; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA.; 6Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA., Mallett CP; 7GSK, Rockville, MD 20850 USA., Innis BL; 8GSK, King of Prussia, PA USA.; 10Present Address: PATH, Washington, DC, USA., Krammer F; 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA., Claeys C; 9GSK, Rixensart, Belgium.; Present Address: Spmt-Arista Asbl, Brussel, Belgium.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2019 Dec 06; Vol. 4, pp. 51. Date of Electronic Publication: 2019 Dec 06 (Print Publication: 2019).
Autor:
Behzadi MA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Leyva-Grado VH; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Namayandeh M; Department of Clinical Virology, Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Namazi Hospital, Shiraz, Iran., Ziyaeyan A; Life Science student, Faculty of Arts and Science, University of Toronto, Toronto, Canada., Feyznezhad R; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Dorzaban H; Hormozgan Health Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran., Jamalidoust M; Department of Clinical Virology, Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Namazi Hospital, Shiraz, Iran., Ziyaeyan M; Department of Clinical Virology, Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Namazi Hospital, Shiraz, Iran. ziyaeyanm@sums.ac.ir.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2019 Dec 03; Vol. 19 (1), pp. 1027. Date of Electronic Publication: 2019 Dec 03.
Autor:
Behzadi MA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Leyva-Grado VH; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Publikováno v:
Frontiers in microbiology [Front Microbiol] 2019 Jun 19; Vol. 10, pp. 1327. Date of Electronic Publication: 2019 Jun 19 (Print Publication: 2019).
Autor:
Behzadi MA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. ma.behzadi@mssm.edu., Stein KR; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Kathryn.Stein@icahn.mssm.edu., Bermúdez-González MC; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. maria.bermudez-gonzalez@mssm.edu.; The Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. maria.bermudez-gonzalez@mssm.edu., Simon V; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. viviana.simon@mssm.edu.; The Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. viviana.simon@mssm.edu.; Division of Infectious Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. viviana.simon@mssm.edu., Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. raffael.nachbagauer@mssm.edu., Tortorella D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. domenico.tortorella@mssm.edu.
Publikováno v:
Vaccines [Vaccines (Basel)] 2019 Jun 14; Vol. 7 (2). Date of Electronic Publication: 2019 Jun 14.